Antioxidant, antitumoral and anti-inflammatory activities of gallic acid

Handbook on Gallic Acid: Natural Occurrences, Antioxidant Properties and Health Implications

Volumn , Issue , 2013, Pages 215-230

  Locatelli, Claudriana ^a,b   Filippin Monteiro, Fabíola Branco ^c   Centa, Ariana ^c   Creczinsky Pasa, Tânia Beatriz ^c  

^a UNIVERSIDADE DO OESTE DE SANTA CATARINA   (Brazil)

^b Informatics Department   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896170586     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Grundhöfer, P.; Niemetz, R.; Schilling, G.; Gross, G. G., Biosynthesis and subcellular distribution of hydrolyzable tannins. Phytochemistry 2001, 57, 915-27.
2. Bucher, D. L., Antioxidants for fish oils. Fishery Market News, 1945; Vol. 7.
3. Thompson, P. E.; Moore, A. M.; Reinertson, J. W., Antimalarial activity of b-resorcylic acid and analogs and reversal by p-hydroxybenzoic acid. Antibiotics and Chemotherapy 1953, 3, 399-408.
4. Mahadevan, A.; Reddy, M. K., The effect of phenolic compounds on growth, polygalacturonase production and activity of Fusarium oxysporum f. vasinfectum. Netherlands Journal of Plant Pathology 1968, 74, 87-90.
5. Florov, A. F.; Mishenkova, E. L., Inhibitory effects of some preparations from higher plants on reproduction of influenza virus in vitro and in vivo. Mikrobiol Zh 1970, 32, 628-33.
6. Kawada, M.; Ohno, Y.; Ri, Y.; Ikoma, T.; Yuugetu, H.; Asai, T.; Watanabe, M.; Yasuda, N.; Akao, S.; Takemura, G.; Minatoguchi, S.; Gotoh, K.; Fujiwara, H.; Fukuda, K., Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anticancer Drugs 2001, 12, 847-52.
7. Ohno, T.; Inoue, M.; Ogihara, Y., Cytotoxic activity of gallic acid against liver metastasis of mastocytoma cells P-815. Anticancer Res 2001, 21, 3875-80.
8. Yang, F.; Oz, H. S.; Barve, S.; de Villiers, W. J.; McClain, C. J.; Varilek, G. W., The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 2001, 60, 528-33.
9. van der Heijden, C. A.; Janssen, P. J.; Strik, J. J., Toxicology of gallates: a review and evaluation. Food Chem Toxicol 1986, 24, 1067-70.
10. Locatelli, C.; Carvalho, D. R.; Mascarello, A.; de Cordova, C. A.; Yunes, R. A.; Nunes, R. J.; Pilati, C.; Creczynski-Pasa, T. B., Antimetastatic activity and low systemic toxicity of tetradecyl gallate in a preclinical melanoma mouse model. Invest New Drugs 2011.
11. Davies, K. J., Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000, 50, 279-89.
12. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M. T.; Mazur, M.; Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39, 44-84.
13. Sakagami, H.; Satoh, K.; Kochi, M., Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview). Anticancer Res 1997, 17, 4451-2.
14. Inoue, M.; Sakaguchi, N.; Isuzugawa, K.; Tani, H.; Ogihara, Y., Role of reactive oxygen species in gallic acid-induced apoptosis. Biological & Pharmaceutical Bulletin 2000, 23, 1153-1157.
15. You, B. R.; Park, W. H., Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. Toxicol In Vitro 2010, 24, 1356-62.
16. Ow, Y. Y.; Stupans, I., Gallic acid and gallic acid derivatives: Effects on drug metabolizing enzymes. Current Drug Metabolism 2003, 4, 241-248.
17. Yeh, C. T.; Ching, L. C.; Yen, G. C., Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. J Nutr Biochem 2009, 20, 163-71.
18. Yeh, C. T.; Yen, G. C., Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. J Nutr 2006, 136, 11-5.
19. Ferk, F.; Chakraborty, A.; Jäger, W.; Kundi, M.; Bichler, J.; Mišík, M.; Wagner, K. H.; Grasl-Kraupp, B.; Sagmeister, S.; Haidinger, G.; Hoelzl, C.; Nersesyan, A.; Dušinská, M.; Simić, T.; Knasmüller, S., Potent protection of gallic acid against DNA oxidation: results of human and animal experiments. Mutat Res 2011, 715, 61-71.
20. Chen, C.; Tang, H. R.; Sutcliffe, L. H.; Belton, P. S., Green tea polyphenols react with 1,1-diphenyl-2-picrylhydrazyl free radicals in the bilayer of liposomes: direct evidence from electron spin resonance studies. J Agric Food Chem 2000, 48, 5710-4.
21. Hashimoto, T.; Kumazawa, S.; Nanjo, F.; Hara, Y.; Nakayama, T., Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 1999, 63, 2252-5.
22. Lu, Z.; Nie, G.; Belton, P. S.; Tang, H.; Zhao, B., Structure-activity relationship analysis of antioxidant ability and neuroprotective effect of gallic acid derivatives. Neurochem Int 2006, 48, 263-74.
23. Saeki, K.; Yuo, A.; Isemura, M.; Abe, I.; Seki, T.; Noguchi, H., Apoptosis-inducing activity of lipid derivatives of gallic acid. Biol Pharm Bull 2000, 23, 1391-4.
24. Serrano, A.; Palacios, C.; Roy, G.; Cespon, C.; Villar, M. L.; Nocito, M.; Gonzalez-Porque, P., Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Archives of Biochemistry and Biophysics 1998, 350, 49-54.
25. Fiuza, S. M.; Gomes, C.; Teixeira, L. J.; Girão da Cruz, M. T.; Cordeiro, M. N.; Milhazes, N.; Borges, F.; Marques, M. P., Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem 2004, 12, 3581-9.
26. Sakaguchi, N.; Inoue, M.; Ogihara, Y., Reactive oxygen species and intracellular Ca2+, common signals for apoptosis induced by gallic acid. Biochemical Pharmacology 1998, 55, 1973-1981.
27. Isuzugawa, K.; Inoue, M.; Ogihara, Y., Ca2+-dependent caspase activation by gallic acid derivatives. Biological & Pharmaceutical Bulletin 2001, 24, 844-847.
28. Jacobi, H.; Hinrichsen, M. L.; Wess, D.; Witte, I., Induction of lipid peroxidation in human fibroblasts by the antioxidant propyl gallate in combination with copper(II). Toxicology Letters 1999, 110, 183-190.
29. Kobayashi, H.; Oikawa, S.; Hirakawa, K.; Kawanishi, S., Metal-mediated oxidative damage to cellular and isolated DNA by gallic acid, a metabolite of antioxidant propyl gallate. Mutation Research-Genetic Toxicology and Environmental Mutagenesis 2004, 558, 111-120.
30. Locatelli, C.; Leal, P. C.; Yunes, R. A.; Nunes, R. J.; Creczynski-Pasa, T. B., Gallic acid ester derivatives induce apoptosis and cell adhesion inhibition in melanoma cells: The relationship between free radical generation, glutathione depletion and cell death. Chem Biol Interact 2009, 181, 175-84.
31. Meyskens, F. L.; Buckmeier, J. A.; McNulty, S. E.; Tohidian, N. B., Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress. Clinical Cancer Research 1999, 5, 1197-1202.
32. Locatelli, C.; Rosso, R.; Santos-Silva, M. C.; de Souza, C. A.; Licinio, M. A.; Leal, P.; Bazzo, M. L.; Yunes, R. A.; Creczynski-Pasa, T. B., Ester derivatives of gallic acid with potential toxicity toward L1210 leukemia cells. Bioorganic & Medicinal Chemistry 2008, 16, 3791-3799.
33. de Cordova, C. A. S.; Locatelli, C.; Assuncao, L. S.; Mattei, B.; Mascarello, A.; Winter, E.; Nunes, R. J.; Yunes, R. A.; Creczynski-Pasa, T. B., Octyl and dodecyl gallates induce oxidative stress and apoptosis in a melanoma cell line. Toxicology in Vitro 2011, 25, 2025-2034.
34. Feng, Q.; Kumagai, T.; Nakamura, Y.; Uchida, K.; Osawa, T., Correlation of antimutagenic activity and suppression of CYP1A with the lipophilicity of alkyl gallates and other phenolic compounds. Mutat Res 2003, 537, 101-8.
35. Inoue, M.; Suzuki, R.; Sakaguchi, N.; Li, Z.; Takeda, T.; Ogihara, Y.; Jiang, B. Y.; Chen, Y., Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull 1995, 18, 1526-30.
36. Ohnishi, T.; Salerno, J. C., Conformation-driven and semiquinone-gated proton-pump mechanism in the NADH-ubiquinone oxidoreductase (complex I). FEBS Lett 2005, 579, 4555-61.
37. Shi, L.; Pardini, R. S., Effect of NDGA on beef heart mitochondria and EMT6 mouse mammary carcinoma cells. Res Commun Mol Pathol Pharmacol 1995, 90, 235-54.
38. Gut, I.; Nedelcheva, V.; Soucek, P.; Stopka, P.; Tichavská, B., Cytochromes P450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ Health Perspect 1996, 104 Suppl 6, 1211-8.
39. Ho, H. H.; Chang, C. S.; Ho, W. C.; Liao, S. Y.; Wu, C. H.; Wang, C. J., Antimetastasis effects of gallic acid on gastric cancer cells involves inhibition of NFkappaB activity and downregulation of PI3K/AKT/small GTPase signals. Food Chem Toxicol 2010, 48, 2508-16.
40. Lu, Y.; Jiang, F.; Jiang, H.; Wu, K.; Zheng, X.; Cai, Y.; Katakowski, M.; Chopp, M.; To, S. S., Gallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells. Eur J Pharmacol 2010, 641, 102-7.
41. Weng, C. J.; Yen, G. C., Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 2012, 38, 76-87.
42. Libra, M.; Scalisi, A.; Vella, N.; Clementi, S.; Sorio, R.; Stivala, F.; Spandidos, D. A.; Mazzarino, C., Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int J Oncol 2009, 34, 897-903.
43. Cheng, J. C.; Chou, C. H.; Kuo, M. L.; Hsieh, C. Y., Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 2006, 25, 7009-18.
44. Javelaud, D.; Poupon, M. F.; Wietzerbin, J.; Besançon, F., Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. Int J Cancer 2002, 98, 193-8.
45. Park, J. M.; Kim, A.; Oh, J. H.; Chung, A. S., Methylseleninic acid inhibits PMAstimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. Carcinogenesis 2007, 28, 837-47.
46. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y.; Mills, G. B., Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005, 4, 988-1004.
47. Ho, H. H.; Chang, C. S.; Ho, W. C.; Liao, S. Y.; Lin, W. L.; Wang, C. J., Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicol Appl Pharmacol 2013, 266, 76-85.
48. Lu, X.; Lu, D.; Scully, M.; Kakkar, V., ADAM Proteins-Therapeutic Potential in Cancer. Current Cancer Drug Targets 2008, 8, 720-732.
49. Kheradmand, F.; Werb, Z., Shedding light on sheddases: role in growth and development. Bioessays 2002, 24, 8-12.
50. Wildeboer, D.; Naus, S.; Sang, Q.-X. A.; Bartsch, J. W.; Pagenstecher, A., Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. Journal of Neuropathology and Experimental Neurology 2006, 65, 516-527.
51. Bernhaus, A.; Fritzer-Szekeres, M.; Grusch, M.; Saiko, P.; Krupitza, G.; Venkateswarlu, S.; Trimurtulu, G.; Jaeger, W.; Szekeres, T., Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells. Cancer Lett 2009, 274, 299-304.
52. Nocentini, G., Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy. Crit Rev Oncol Hematol 1996, 22, 89-126.
53. Horvath, Z.; Saiko, P.; Illmer, C.; Madlener, S.; Hoechtl, T.; Bauer, W.; Erker, T.; Jaeger, W.; Fritzer-Szekeres, M.; Szekeres, T., Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Exp Hematol 2005, 33, 329-35.
54. Madlener, S.; Illmer, C.; Horvath, Z.; Saiko, P.; Losert, A.; Herbacek, I.; Grusch, M.; Elford, H. L.; Krupitza, G.; Bernhaus, A.; Fritzer-Szekeres, M.; Szekeres, T., Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Letters 2007, 245, 156-162.
55. Liang, Y. C.; Tsai, S. H.; Chen, L.; Lin-Shiau, S. Y.; Lin, J. K., Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol 2003, 65, 1053-60.
56. Tang, X. M.; Sun, Y. J.; Half, E.; Kuo, M. T.; Sinicrope, F., Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumornecrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Cancer Research 2002, 62, 4903-4908.
57. Rizzo, M. T., Cyclooxygenase-2 in oncogenesis. Clinica Chimica Acta 2011, 412, 671-687.
58. Kitagawa, S.; Nabekura, T.; Kamiyama, S.; Takahashi, T.; Nakamura, Y.; Kashiwada, Y.; Ikeshiro, Y., Effects of alkyl gallates on P-glycoprotein function. Biochemical Pharmacology 2005, 70, 1262-1266.
59. Calcabrini, A.; Garcia-Martinez, J. M.; Gonzalez, L.; Julian Tendero, M.; Agullo Ortuno, M. T.; Crateri, P.; Lopez-Rivas, A.; Arancia, G.; Gonzalez-Porque, P.; Martin-Perez, J., Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate. Carcinogenesis 2006, 27, 1699-1712.
60. Arfan, M.; Amin, H.; Khan, N.; Khan, I.; Saeed, M.; Khan, M. A.; Fazal-ur-Rehman, Analgesic and anti-inflammatory activities of 11-O-galloylbergenin. J Ethnopharmacol 2010, 131, 502-4.
61. Na, H. J.; Lee, G.; Oh, H. Y.; Jeon, K. S.; Kwon, H. J.; Ha, K. S.; Lee, H.; Kwon, Y. G.; Kim, Y. M., 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-kappaB activation. Int Immunopharmacol 2006, 6, 1597-608.
62. Chang, Y. H.; Lee, S. T.; Lin, W. W., Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J Cell Biochem 2001, 81, 715-23.
63. Azzolina, A.; Bongiovanni, A.; Lampiasi, N., Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 2003, 1643, 75-83.
64. Beyaert, R.; Cuenda, A.; Vanden Berghe, W.; Plaisance, S.; Lee, J. C.; Haegeman, G.; Cohen, P.; Fiers, W., The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 1996, 15, 1914-23.
65. Lee, G.; Na, H. J.; Namkoong, S.; Jeong Kwon, H.; Han, S.; Ha, K. S.; Kwon, Y. G.; Lee, H.; Kim, Y. M., 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity. Eur J Pharmacol 2006, 551, 143-51.
66. Ghosh, S.; May, M. J.; Kopp, E. B., NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16, 225-60.
67. Choi, K. C.; Lee, Y. H.; Jung, M. G.; Kwon, S. H.; Kim, M. J.; Jun, W. J.; Lee, J.; Lee, J. M.; Yoon, H. G., Gallic acid suppresses lipopolysaccharide-induced nuclear factorkappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 2009, 7, 2011-21.
68. Jung, H. J.; Kim, S. J.; Jeon, W. K.; Kim, B. C.; Ahn, K.; Kim, K.; Kim, Y. M.; Park, E. H.; Lim, C. J., Anti-inflammatory activity of n-propyl gallate through down-regulation of NF-κB and JNK pathways. Inflammation 2011, 34, 352-61.
69. Yoon, C. H.; Chung, S. J.; Lee, S. W.; Park, Y. B.; Lee, S. K.; Park, M. C., Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine 2012.
70. Chandramohan Reddy, T.; Bharat Reddy, D.; Aparna, A.; Arunasree, K. M.; Gupta, G.; Achari, C.; Reddy, G. V.; Lakshmipathi, V.; Subramanyam, A.; Reddanna, P., Antileukemic effects of gallic acid on human leukemia K562 cells: downregulation ofCOX-2, inhibition of BCR/ABL kinase and NF-κB inactivation. Toxicol In Vitro 2012, 26, 396-405.
71. Wang, M. T.; Honn, K. V.; Nie, D., Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 2007, 26, 525-34.
72. Jagan, S.; Ramakrishnan, G.; Anandakumar, P.; Kamaraj, S.; Devaki, T., Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma. Mol Cell Biochem 2008, 319, 51-9.
73. Madlener, S.; Illmer, C.; Horvath, Z.; Saiko, P.; Losert, A.; Herbacek, I.; Grusch, M.; Elford, H. L.; Krupitza, G.; Bernhaus, A.; Fritzer-Szekeres, M.; Szekeres, T., Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett 2007, 245, 156-62.
74. Frankel, E. N.; Kanner, J.; German, J. B.; Parks, E.; Kinsella, J. E., Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341, 454-7.
75. Hidalgo, M.; Martin-Santamaria, S.; Recio, I.; Sanchez-Moreno, C.; de Pascual-Teresa, B.; Rimbach, G.; de Pascual-Teresa, S., Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr 2012, 7, 295-306.
76. Shahrzad, S.; Aoyagi, K.; Winter, A.; Koyama, A.; Bitsch, I., Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 2001, 131, 1207-10.
77. Yan, J.; Chen, Y.; He, C.; Yang, Z. Z.; Lü, C.; Chen, X. S., Andrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes. Cell Biol Toxicol 2012, 28, 47-56.
78. Kuppan, G.; Balasubramanyam, J.; Monickaraj, F.; Srinivasan, G.; Mohan, V.; Balasubramanyam, M., Transcriptional regulation of cytokines and oxidative stress by gallic acid in human THP-1 monocytes. Cytokine 2010, 49, 229-34.
79. Kim, S. H.; Jun, C. D.; Suk, K.; Choi, B. J.; Lim, H.; Park, S.; Lee, S. H.; Shin, H. Y.; Kim, D. K.; Shin, T. Y., Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 2006, 91, 123-31.
80. Kim, M. J.; Seong, A. R.; Yoo, J. Y.; Jin, C. H.; Lee, Y. H.; Kim, Y. J.; Lee, J.; Jun, W. J.; Yoon, H. G., Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol Nutr Food Res 2011, 55, 1798-808.
81. Mattson, M. P., Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp Gerontol 2000, 35, 489-502.